- Home
- WNC vs RLMD Comparison
WNC vs RLMD Comparison
Compare WNC & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WNC | RLMD |
|---|---|---|
| Founded | 1985 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 392.2M | 319.7M |
| IPO Year | 2009 | 2012 |
Fundamental Metrics
Financial Performance| Metric | WNC | RLMD |
|---|---|---|
| Price | $9.02 | $6.32 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $11.00 | $10.25 |
| AVG Volume (30 Days) | 534.2K | ★ 1.3M |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.49% | N/A |
| EPS Growth | ★ 179.22 | 19.21 |
| EPS | ★ 5.07 | N/A |
| Revenue | ★ $2,027,489,000.00 | $13,070.00 |
| Revenue This Year | $0.53 | N/A |
| Revenue Next Year | $25.53 | N/A |
| P/E Ratio | $1.82 | ★ N/A |
| Revenue Growth | 8.81 | ★ 154.83 |
| 52 Week Low | $6.78 | $0.24 |
| 52 Week High | $12.94 | $7.41 |
Technical Indicators
Market Signals| Indicator | WNC | RLMD |
|---|---|---|
| Relative Strength Index (RSI) | 33.20 | 64.05 |
| Support Level | $8.41 | $3.65 |
| Resistance Level | $9.39 | N/A |
| Average True Range (ATR) | 0.47 | 0.47 |
| MACD | -0.20 | 0.24 |
| Stochastic Oscillator | 13.41 | 64.53 |
Price Performance
Historical ComparisonAbout WNC Wabash National Corporation
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.